Skip to content

Gilead acquires Triangle, will push for tenofovir and FTC in one tablet

Business Coalition aims for HIV programmes as corporate norm

Men with metabolic syndrome around three times more likely to die of heart disease

How long can HIV treatment be spared once the CD4 count falls below 350?

New single tablet version of efavirenz now available in UK

India to tell blood donors if they have HIV

WTO talks on cheap HIV drugs stall again

New UK HIV cases predicted to increase by 25% in 2002

Study shows tenofovir's promise as treatment for people with HIV/HBV coinfection